Pain and fibromyalgia

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 9, Issue 5, 2009, Pages 162-166

  Dedhia, Jatin D ^a   Bone, Margaret E ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349433692     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mkp026     Document Type: Article

References (10)

1. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72
2. Giamberardino MA. Update on Fibromyalgia Syndrome. Pain: Clinical Updates, Vol. 4. 2008; 1-6
3. Schneider MJ. Tender points/fibromyalgia vs. trigger points/myofascial pain syndrome: A need for clarity in terminology and differential diagnosis. J Manipulative Physiol Ther 1995; 18: 398-406
4. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia and temporomandibular disorders. Arch Intern Med 2000; 160: 221-7
5. Wolfe L, Cathey MA, Kleinheksel SM. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol 1984; 11: 814-8
6. Abeles AM, Pillinger MH, Solitar BM, Abeles M. The pathophysiology of fibromyalgia. Ann Intern Med 2007; 146: 726-34
7. Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures and treatment. J Rheumatol 2005; 32: 6-21
8. Carville SF, Nielsen SA, Bliddal H et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008; 67: 536-41
9. Anselm M, Li EK. Pathogenesis, diagnosis and treatment of fibromyalgia: an update. Hong Kong Bull Rheum Dis 2003; 2: 60-6
10. Raphael JH, Southall JL, Treharne GJ, Kitas GD. Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome. BMC Musculoskelet Disord 2002; 3: 21-8